InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Glickman Sarah JS, Chief Financial Officer. Officer active across 3 companies, notably bluebird bio, Inc.. In total, 8 reports have been published. History available since 29 September 2021. The latest transaction was filed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations8 total
4,200 shares0Common StockSEC:0001562180-22-004991:0
36,808 shares0Ordinary SharesSEC:0001576427-22-000014:0
00Common StockSEC:0001628280-21-023646:0
00Common StockSEC:0001628280-21-023646
3,002 shares0Common StockSEC:0001628280-21-023466:0
3,002 shares0Common StockSEC:0001628280-21-023466
4,663 shares0Common StockSEC:0001562180-21-006221:0
4,663 shares0Common StockSEC:0001562180-21-006221
8 of 8 declarations
About Glickman Sarah JS
Sarah JS Glickman is a Board Member and Chief Financial Officer at bluebird bio, Inc., 2seventy bio, Inc., and Criteo S.A. She oversees financial operations and is responsible for strategic planning. Her role is crucial in ensuring the financial health of these companies and supporting their growth in the biopharmaceutical sector.
